Cargando…

PB1888: TRIAL IN PROGRESS: PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE OR MAGROLIMAB FOR PATIENTS WITH CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)

Detalles Bibliográficos
Autores principales:	Daver, Naval, Montesinos, Pau, Aribi, Ahmed, Martinelli, Giovanni, Wang, Eunice, Altman, Jessica, Roboz, Gail, Burke, Patrick, Walter, Roland, Benga, Kebede, Sloss, Callum, Malcolm, Kara, Zweidler-Mckay, Patrick, Sweet, Kendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429871/ http://dx.doi.org/10.1097/01.HS9.0000974376.12654.b3

Ejemplares similares

S139: INTERIM ANALYSIS OF A REGISTRATION ENABLING STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) A CD123-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
por: Pemmaraju, Naveen, et al.
Publicado: (2023)

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN
por: Pemmaraju, N., et al.
Publicado: (2022)

CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia
por: Angelova, Evgeniya, et al.
Publicado: (2019)

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results
por: Daver, Naval G., et al.
Publicado: (2023)

S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE 1B RESULTS
por: Daver, N. G., et al.
Publicado: (2022)

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models
por: Hicks, Stuart W., et al.
Publicado: (2017)

1888
Publicado: (1889)

632. Recurrent Pneumococcal Meningitis in Adults
por: Lauter, Carl, et al.
Publicado: (2018)

1888 : antología conmemorativa.
Publicado: (1988)

A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
por: Paul, Barry, et al.
Publicado: (2023)

PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Paul, B., et al.
Publicado: (2022)

The Lettsomian Lectures for 1888
Publicado: (1888)

Pharmacology and Therapeutics in 1888
Publicado: (1889)

P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA
por: Koenig, Kristin, et al.
Publicado: (2023)

PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML
por: Daver, N., et al.
Publicado: (2022)

P1003: RUXOLITINIB AND MAGROLIMAB INCREASES CALRETICULIN IN MYELOFIBROSIS CD34+ CELLS IN VITRO. PROOF OF CONCEPT FOR COMBINATION THERAPY.
por: Rinaldi, Ciro, et al.
Publicado: (2023)

Correction to Lancet Haematol 2020; 7: e632–34
Publicado: (2020)

P567: PHASE 1B OMNIVERSE TRIAL: SAFETY AND TOLERABILITY OF ORAL AZACITIDINE IN COMBINATION WITH VENETOCLAX FOR TREATMENT OF ACUTE MYELOID LEUKEMIA
por: Fleming, Shaun, et al.
Publicado: (2023)

Poesía completa (1869-1888)
por: Nietzsche, Friedrich Wilhelm, 1844-1900
Publicado: (2008)

Poéte pluriel (1888-1935).
por: Pessoa, Fernando, 1888-1935
Publicado: (1985)

The Kashmir Cholera Epidemic of 1888
por: Neve, Arthur
Publicado: (1889)

Annals of Surgery for June 1888
Publicado: (1888)

The Year-Book of Treatment for 1888
Publicado: (1888)

Annals of Surgery, September 1888
Publicado: (1888)

The Year-Book of Treatment for 1888
Publicado: (1888)

The Physician's Visiting List, 1888
Publicado: (1888)

The Year-Book of Treatment for 1888
Publicado: (1888)

CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
por: Bankur, Mustafa Nissar, et al.
Publicado: (2022)

Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023)

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
por: Short, Nicholas J., et al.
Publicado: (2023)

P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY
por: Short, Nicholas, et al.
Publicado: (2023)

Micro-RNA-632 down regulates DNAJB6 in breast cancer
por: Mitra, Aparna, et al.
Publicado: (2012)

Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia
por: Ramdohr, Florian, et al.
Publicado: (2022)

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023)

The army of the German Empire, 1870-1888 /
por: Seaton, Albert, 1921-
Publicado: (1973)

Metropolitan Hospital Sunday Fund, 1888
Publicado: (1888)

American Medical Association, May, 1888
Publicado: (1888)

Transactions of the International Hahnemannian Association for 1888
Publicado: (1889)

Report of the Homœopathic Hospital at Melbourne, 1888
Publicado: (1889)

Odontological Society of Pennsylvania: November, 1888
por: Baumgardner, I. G.
Publicado: (1889)

Cannot write session to /tmp/vufind_sessions/sess_19n2ojpep69i3a6ae8nd4dl70c